ExodusPoint Capital Management’s SpringWorks Therapeutics SWTX Stock Holding History

ExodusPoint Capital Management’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-100,000	Closed	-$4.7M	–	2004
2025 Q2	$4.7M	Buy	100,000 +50,000	+100%	+$2.22M	0.04%	447
2025 Q1	$2.21M	Buy	+50,000	New	+$2.3M	0.02%	666
2024 Q2	–	Sell	-5,000	Closed	-$246K	–	1969
2024 Q1	$246K	Buy	+5,000	New	+$231K	﹤0.01%	1308

Other funds holding SWTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

ExodusPoint Capital Management's SWTX Position: Q2 2025 in Review

ExodusPoint Capital Management sold out of SpringWorks Therapeutics (SWTX) in Q2 2025, closing a stake of 17,785 shares — an estimated $791K sold.

ExodusPoint Capital Management first reported a position in SWTX in Q1 2020 and held it in 10 quarters. The position peaked at $5.36M in Q2 2024. 222 funds tracked by Wall St. Rank hold SWTX as of Q2 2025.

ExodusPoint Capital Management reported no remaining SpringWorks Therapeutics position as of Q2 2025 after selling out during the quarter.
ExodusPoint Capital Management sold 17,785 SpringWorks Therapeutics shares in Q2 2025, an estimated $791K.
ExodusPoint Capital Management first reported a position in SpringWorks Therapeutics in Q1 2020 and held it in 10 quarters.
ExodusPoint Capital Management's SpringWorks Therapeutics position peaked at $5.36M in Q2 2024.
222 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q2 2025.

Based on ExodusPoint Capital Management's 13F filing for Q2 2025, filed 13 Aug 2025.